Hong Kong SAR, China - Antisera And Other Blood Fractions - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingAntisera Price in Hong Kong SAR - 2022
Contents:
- Antisera Price in Hong Kong SAR (CIF) - 2022
- Antisera Price in Hong Kong SAR (FOB) - 2022
- Antisera Imports in Hong Kong SAR
- Antisera Exports in Hong Kong SAR
Antisera Price in Hong Kong SAR (CIF) - 2022
In 2022, the average antisera import price amounted to $299,371 per ton, growing by 7.4% against the previous year. Overall, the import price recorded a relatively flat trend pattern. The pace of growth was the most pronounced in 2015 an increase of 21% against the previous year. The import price peaked at $301,967 per ton in 2020; however, from 2021 to 2022, import prices failed to regain momentum.
Average prices varied noticeably amongst the major supplying countries. In 2022, amid the top importers, the countries with the highest prices were China ($299,377 per ton) and Australia ($299,375 per ton), while the price for Ireland ($299,360 per ton) and Sweden ($299,367 per ton) were amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Sweden (+3.3%), while the prices for the other major suppliers experienced more modest paces of growth.
Antisera Price in Hong Kong SAR (FOB) - 2022
The average antisera export price stood at $295,394 per ton in 2022, increasing by 4.5% against the previous year. Over the period from 2012 to 2022, it increased at an average annual rate of +1.9%. The most prominent rate of growth was recorded in 2016 when the average export price increased by 16% against the previous year. As a result, the export price attained the peak level of $295,597 per ton. From 2017 to 2022, the average export prices failed to regain momentum.
Average prices varied noticeably for the major overseas markets. In 2022, amid the top suppliers, the highest price was recorded for prices to Italy ($288,997 per ton) and Cambodia ($288,785 per ton), while the average price for exports to Macao SAR ($286,163 per ton) and China ($286,194 per ton) were amongst the lowest.
From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Sweden (+15.7%), while the prices for the other major destinations experienced more modest paces of growth.
Antisera Imports in Hong Kong SAR
In 2022, approx. 807 tons of antisera and other blood fractions were imported into Hong Kong SAR; with an increase of 21% against 2021. In general, total imports indicated a buoyant increase from 2019 to 2022: its volume increased at an average annual rate of +19.2% over the last three-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by +69.5% against 2019 indices. As a result, imports reached the peak and are likely to continue growth in the immediate term.
In value terms, antisera imports skyrocketed to $242M in 2022. Over the period under review, total imports indicated a significant increase from 2019 to 2022: its value increased at an average annual rate of +20.2% over the last three-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by +73.5% against 2019 indices. As a result, imports reached the peak and are likely to continue growth in the immediate term.
| Import of Antisera in Hong Kong SAR (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| Switzerland | 39.4 | 47.5 | 48.8 | 75.6 | 24.3% |
| United States | 23.0 | 26.9 | 34.2 | 36.1 | 16.2% |
| Germany | 32.4 | 38.5 | 36.0 | 35.1 | 2.7% |
| Singapore | 13.5 | 18.9 | 30.8 | 28.7 | 28.6% |
| Belgium | 2.8 | 9.1 | 6.9 | 14.8 | 74.2% |
| Netherlands | 3.2 | 3.1 | 9.9 | 10.3 | 47.6% |
| United Kingdom | 7.3 | 3.0 | 2.9 | 10.2 | 11.8% |
| Sweden | N/A | N/A | N/A | 8.6 | 0% |
| Ireland | N/A | N/A | N/A | 7.6 | 0% |
| China | 0.6 | 8.5 | 6.0 | 5.7 | 111.8% |
| Australia | 5.5 | 4.6 | 5.0 | 3.8 | -11.6% |
| Others | 11.6 | 10.0 | 5.1 | 5.0 | -24.5% |
| Total | 139 | 170 | 186 | 242 | 20.3% |
Top Suppliers of Antisera to Hong Kong SAR in 2022:
- Switzerland (252.4 tons)
- United States (120.6 tons)
- Germany (117.3 tons)
- Singapore (95.8 tons)
- Belgium (49.5 tons)
- Netherlands (34.5 tons)
- United Kingdom (34.2 tons)
- Sweden (28.8 tons)
- Ireland (25.4 tons)
- China (19.1 tons)
- Australia (12.7 tons)
Antisera Exports in Hong Kong SAR
In 2022, shipments abroad of antisera and other blood fractions increased by 1.9% to 96 tons for the first time since 2019, thus ending a two-year declining trend. In general, exports, however, continue to indicate a sharp curtailment.
In value terms, antisera exports expanded remarkably to $28M in 2022. Overall, exports, however, showed a dramatic slump.
| Export of Antisera in Hong Kong SAR (Million USD) | |||||
|---|---|---|---|---|---|
| COUNTRY | 2019 | 2020 | 2021 | 2022 | CAGR, 2019-2022 |
| Macao SAR | 13.7 | 11.0 | 17.3 | 14.2 | 1.2% |
| China | 189 | 141 | 4.7 | 7.7 | -65.6% |
| Italy | 0.2 | 0.8 | 1.2 | 3.5 | 159.6% |
| Argentina | 0.5 | 0.9 | 1.0 | 0.6 | 6.3% |
| Cambodia | 0.1 | 0.1 | N/A | 0.5 | 71.0% |
| South Korea | 8.9 | 2.0 | 1.0 | 0.1 | -77.6% |
| Others | 0.7 | 1.0 | 1.3 | 1.9 | 39.5% |
| Total | 213 | 157 | 26.7 | 28.4 | -48.9% |
Top Export Markets for Antisera from Hong Kong SAR in 2022:
- Macao SAR (49.8 tons)
- China (26.8 tons)
- Italy (12.0 tons)
- Argentina (2.1 tons)
- Cambodia (1.7 tons)
- South Korea (0.2 tons)
This report provides an in-depth analysis of the antisera market in Hong Kong SAR, China. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21202125 - Antisera, other immunological products which are directly involved in the regulation of immunological processes and other blood fractions
Country coverage:
- Hong Kong SAR
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Hong Kong SAR, China
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
318
This report provides an in-depth analysis of the antisera market in Hong Kong SAR, China.
290
This report provides an in-depth analysis of the biological product market in Hong Kong SAR, China.
339
This report provides an in-depth analysis of the vaccine market in Hong Kong SAR, China.
365
This report provides an in-depth analysis of the market for human and animal blood in Hong Kong SAR, China.
386
This report provides an in-depth analysis of the veterinary medicine vaccines market in Hong Kong SAR, China.
2284
This report provides an in-depth analysis of the global antisera market.
559
This report provides an in-depth analysis of the global biological product market.
2846
This report provides an in-depth analysis of the global vaccine market.
646
This report provides an in-depth analysis of the global market for human and animal blood.
753
This report provides an in-depth analysis of the global veterinary medicine vaccines market.
272
Explore the top import markets for antisera and their key statistics. Find out which countries dominate the global import market for antisera and their import values.
1149
Global trade in antisera and other blood fractions reached the highest level ever, totalling near $182B in 2020. The U.S., Germany, China, Spain, the UK and South Korea top the world’s largest antisera exporter ranking, comprising 67% of the total shipments. More than half of antisera imports are supplied to Germany, the U.S., Austria, Spain, Italy, China and Switzerland.
1075
In 2016, the antisera and other blood fractions market grew by X% to X billion USD. From 2007 to 2016, the global value of consumption of antisera and other blood fractions almost doubled, which was due to the rising demand in developing countries.
1256
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
1263
In 2016, the global imports of antisera stood at X tons, moving up by X% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prom...
3232
From 2007 to 2015, global exports of antisera and other blood fractions showed steady growth, amounting to X million USD in 2015. There was an annual increase of +X% throughout the analyzed period.
501
Switzerland seized control of the antisera and other blood fractions market. In 2014, Switzerland exported X thousand tons of antisera and other blood fractions totaling X billion USD, X% over the previous year. Its primary trading partner was G
237
Explore the top import markets for Biological Products worldwide, including the United States, Germany, Belgium, and more. Discover key statistics and import values in this article.
592
Due to widespread Covid vaccination rates, the global trade in vaccines reached $42.5B, the highest level ever. Belgium topped the country rankings by the value of exports this year, followed by Germany and the U.S. Growing global demand stimulates the rapid expansion of Covid vaccine production facilities in the EU.
1231
Belgium dominates in the global trade of vaccines for human medicine. In 2014, Belgium exported X tons of vaccines for human medicine totaling $X, X% over the previous year. Its primary trading partner was France, where it supplied X% o
